MIOCHOL E Rx
Generic Name and Formulations:
Acetylcholine chloride 20mg, mannitol 56mg; per vial; pwd for reconstitution into intraocular soln.
Valeant Pharmaceuticals, Inc
Indications for MIOCHOL E:
To obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.
Prepare soln immediately before use. Syringe filter has priming volume of 0.6mL. Instill into the anterior chamber before or after securing one or more sutures. 0.5–2mL produces satisfactory miosis.
Open under aseptic conditions only.
May be antagonized by topical NSAIDs.
Ocular effects (eg, corneal edema/clouding/decompensation); rare: systemic effects (eg, bradycardia, hypotension, flushing, breathing difficulties, sweating).
Blister pack—1 (vial + electrolyte diluent + sterile filter)
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|